C
annabinoids are the principal psychoactive component of marijuana and hashish, acting on an intrinsic G proteincoupled receptor in nervous tissue that normally responds to endogenous ligands such as anandamide (arachidonylethanolamide, or AEA) (1) . Despite considerable recent progress, the mechanisms of cannabinoid action in the body remain poorly understood, particularly in the case for the role of cannabinoids in vision. Published research and case studies as well as a host of anecdotal reports describe numerous effects on visual perception including altered thresholds of light detection and glare recovery (2) (3) (4) . The possible loci within the retina and͞or brain responsible for these perceptual changes are unknown. Our report may identify one of the major sites responsible for the alterations in the visual world of some cannabinoid users.
The first cannabinoid receptor, CB1, was cloned in 1990 (5) . Since then the CB1 receptor has been found to be expressed at high levels in specific brain regions (6) . Putative endogenous ligands have been identified: anandamide (1) and 2-arachidonylglycerol (2-AG) (7) . Endogenous cannabinoids have been shown to produce effects on memory, signaling pathways, and the perception of pain, (8) (9) (10) (11) (12) (13) (14) and have even been found to inhibit dopamine release in the leech (15) , implying an inveterate history as a neuromodulatory system. Recent evidence suggests that cannabinoid receptors are found in the retina, with one study demonstrating an anandamide-induced inhibition of dopamine release (16) and another study showing expression of CB1 mRNA through in situ labeling in embryonic rat retina (17) . Recently, Porcella et al. (18) have found mRNA for CB1 in retina, by using reverse transcription-PCR. However neither precise localization of the expression of CB1 receptor protein, nor localization of cannabinoids, has been reported in vertebrate retina.
The goal of our study was to determine the cellular localization of cannabinoid receptors and the presence of putative endogenous ligands anandamide and 2-AG in the vertebrate retina and to explore the physiology of cannabinoid receptor activation. Here we report that CB1 receptors are found in the outer plexiform layer (OPL) and inner plexiform layer (IPL) of the six species examined: the rhesus monkey, the mouse, the rat, the chick, the goldfish, and the tiger salamander. We have determined that 2-AG, the endogenous ligand for CB1, and palmitylethanolamide (PEA), a putative endogenous ligand for the CB2 receptor (19) , are present in rat retina at concentrations similar to those seen elsewhere in the brain, but that the rat retina does not contain anandamide. Further, voltage-gated calcium channel activity in retinal bipolar cells of the tiger salamander was modulated by activation of CB1 receptors. These data strongly suggest that an endogenous cannabinoid signaling system is present in the vertebrate retina, and that it may act presynaptically to regulate glutamatergic synaptic transmission.
Materials and Methods
Immunohistochemistry. Eyes from two adult mice (strain C57͞ Black6), five adult Sprague-Dawley rats, two chicks, three larval tiger salamanders, one goldfish, and one adult rhesus monkey were used in these experiments. Mice and rats were anesthetized (210 mg͞kg and 120 mg͞kg sodium pentobarbital, respectively, i.p.) and then killed. Chicks were anesthetized by a combined ketamine (80 mg͞kg) and xylazine (16 mg͞kg) injection and then killed. All animals were sacrificed by decapitation. The eye was promptly dissected out. Fish and salamanders were doublepithed before removal of the eye. Eyes of an adult rhesus monkey were received already fixed in 10% formalin from the primate center at the University of California, Davis. For eyes from all species, anterior eyepoles and vitreous were cut away. The eyecups of all species except monkey were bathed in either 2% or 4% paraformaldehyde made in 0.1 M sodium phosphate buffer at pH 7.4 overnight. After fixation, the eyecups were kept in a 30% sucrose solution in phosphate buffer for at least 48 hr before being frozen in embedding medium. Sections 10 m thick were cut on a cryostat and thaw-mounted onto glass slides (Fisherbrand Superfrost͞Plus, Fisher). All procedures used in this study were approved by the Animal Care Committee of the University of California, San Diego and conform to the guidelines of the National Institutes of Health on the Care and Use of Laboratory Animals.
Slide-mounted sliced retinas were washed in PBS and incuAbbreviations: 2-AG, 2-arachidonyl glycerol; PEA, palmitylethanolamide; INL, inner nuclear layer; IPL, inner plexiform layer; OPL, outer plexiform layer; GCL, ganglion cell layer; OEA, oleylethanolamide.
bated overnight at 4°C with the affinity-purified rabbit polyclonal CB1 receptor antibodies (20) (1:200 dilution for monkey and mouse tissue, 1:500 in chick, fish, and salamander tissue, made in PBS, with 0.3% Triton, 10% nonfat milk). After the overnight incubation, the sections were washed with PBS, and then incubated with lissamine rhodamine goat anti-rabbit antibodies (1:100, Jackson ImmunoResearch) for 90 min at room temperature. Finally, the tissues were washed with PBS and coverslipped with glycerine carbonate. Tissues prepared with 2% vs. 4% paraformaldehyde and tissues fixed for 6 hr (rather than overnight) yielded similar labeling. For the calbindin͞CB1 double-label studies, a 1:4,000 dilution of calbindin (Sigma) and CB1 (concentrations as above) antibodies were simultaneously applied to slide-mounted tissue. The calbindin antibody, made in mouse, then was detected with FITC (1:100) goat anti-mouse antibody (Jackson Laboratories) whereas the CB1 was detected as before by a lissamine rhodamine anti-rabbit antibody. In control experiments, CB1 and calbindin antibodies were omitted to determine the level of background labeling, which was typically low. As a further control, the immunizing protein (1-2 g͞ml) was preincubated and coincubated with the CB1 antibodies. In all cases, CB1 labeling was successfully blocked by inclusion of the immunizing protein. Preincubation and coincubation of CB1 antibody with the NH 2 terminus of CB2 (1-2 g͞ml) did not diminish labeling.
GC͞MS. GC͞MS analysis of endogenous cannabinoids was carried out as described (21), with minor modifications. Briefly, rapidly dissected rat retinas (average weight of Ϸ 20 mg) were immersed in 3 ml of ice-cold methanol containing deuterium-labeled standards (i.e., [ ]-2-arachidonylglycerol), and homogenized. After acetone (6 ml) precipitation of proteins (30 min on ice), the supernatants were collected and reduced to approximately 3 ml under a stream of N2. Lipids were extracted for 30 min with ice-cold chloroform (6 ml). Chloroform phases were separated by adding H 2 O (1.5 ml), and fractionated by open-bed chromatography followed by normal-phase HPLC. Fractions containing endogenous cannabinoid lipids were treated with bis(trimethylsilyl)trifluoroacetamide for 30 min at room temperature and analyzed by electron-impact GC͞MS in the selected-ion monitoring mode. Deuterated standards were prepared as described (21) or purchased from Deva Biotechnology (Hartboro, PA).
Retinal Slices and Whole-Cell Patch Clamp Recording. Retinal slices in larval tiger salamanders (Ambystoma tigrinum) were made in a manner similar to that reported by Werblin (22) . The slices were viewed with differential interference contrast optics with a 40ϫ water immersion objective. Patch recordings of identified retinal bipolar cells (the recorded cell was stained with a fluorescent dye, Calcein) were made by using an EPC-9 amplifier and HEKA software (HEKA Electronics, Lambrecht͞Pfalz, Germany) with methods similar to those reported by Maguire et al. (23) . After recording, the fluorescent cell was viewed with an Olympus confocal laser scanning microscope for morphological identification. Patch pipettes for whole-cell recording contained 104 mM K-gluconate, 12 mM KCl, 0.1 mM CaCl 2 , 4 mM Hepes, 1 mM EGTA, 200 g͞ml amphotericin B, and calcein (0.5% solution). Standard Ringer's contained 120 mM NaCl, 2 mM KCl, 3 mM CaCl 2 , 1 mM MgCl 2 , 4 mM Hepes, 3 mM D-glucose. Ringer's to isolate calcium currents included 50 mM NaCl, 1 mM MgCl 2 , 4 mM Hepes, 3 mM D-glucose, 40 mM tetraethylammonium, 10 mM BaCl 2 .
Results
Though this antibody was made against rat CB1, it also delivered robust and extensive labeling in the retinas of the monkey, mouse, chick, tiger salamander, and goldfish. The pattern of staining was similar in all species. Labeling was found in most layers of the retina and will be presented in order of prominence.
OPL. In the retina of the monkey, antibodies to CB1 intensely labeled the OPL with many roughly spherical-and pyramidalshaped structures that resemble the synaptic terminals of photoreceptors: rod spherules and cone pedicles, respectively ( Fig.  1 c and d) . To determine whether CB1 was specifically located in cone pedicles, CB1 antibodies were coapplied with those against calbindin, a known marker for cone photoreceptors (24) . These results are presented in Fig. 1 c and d for monkey . Calbindin, shown in green, stains the full extent of cones, from the outer segments to their terminals in the OPL. CB1 staining, shown in red, was almost exclusively confined to the pedicle of the cone where there was intense yellow double staining for both substances. This finding confirmed the presence of CB1 in the cone pedicles. The CB1 staining in monkey continued into the thinner pedicle stalk in monkey (Fig. 1d, arrowhead) . We did not perform double-labeling studies in the mouse or rat to determine the presence of CB1 labeling in cones; however, in both species (Figs. 1a and 2a) we detected intense CB1 labeling in the distal OPL, suggesting the presence of CB1 in the synaptic terminals of rod and͞or cone photoreceptors. In chick retina, where a double cone pedicle arises from a thick extension of the double cones, CB1 staining showed an abrupt boundary (Fig. 1b) , suggesting that the receptor is structurally constrained in its cellular distribution. The pattern of labeling corresponded very closely to the three layers of cone photoreceptor pedicles (Fig.  1b) . Labeling was most intense in the OPL layer most proximal to the photoreceptors, a layer devoted to the terminals of double cones (25) and rods, but also could be detected in smaller numbers in layers two and three of the OPL (Fig. 1b, small  arrowheads) . The spherules and pedicles were the most intensely labeled objects in most of the retinas we examined.
In the goldfish, CB1 labeling was detected in a pattern that appeared to correspond closely to the photoreceptor cone pedicles and rod spherules (Fig. 3e) . CB1 labeling also was noted in the OPL of the salamander.
IPL.
In most species CB1 labeling in the IPL was generally robust but diffuse with only slight apparent stratification. The IPL of the primate was labeled in a sparse pattern (Fig. 3a) . CB1 labeling in the mouse and rat (not shown) had little indication of stratification but in the mouse appeared to be more intense close to the inner nuclear layer (INL) and ganglion cell layer (GCL, not shown). The IPL of the chick was faintly but distinctly stratified with more intense labeling close to the INL (Fig. 3c) . In the goldfish and the salamander, the IPL was labeled without any obvious stratification. We did not see labeling of individual processes and as such were unable to assign the labeling to a particular cell type.
Photoreceptor Inner and Outer Segments and Outer Nuclear Layer. In the primate, only photoreceptor inner segments were labeled (Fig. 3 a and b) . In the mouse retina, the photoreceptor layer is composed almost exclusively of rods. Mouse photoreceptor outer segments displayed an endogenous fluorescence; however, immunolabeling above the level of autofluorescence was apparent (not shown). The same was found to be true in the rat except that the labeling appeared in the inner rather than outer segments. Low levels of CB1 labeling also were detected in the outer segments of chick photoreceptors. Circular labeling near the tips of chick photoreceptors is caused by the presence of oil droplets but is not related to the presence of CB1. In the remaining species we did not detect labeling in the inner or outer segments above the level of autofluorescence. In every species examined, the inner͞outer segment labeling was much less pronounced than in the pedicles and spherules.
INL. Labeling in the INL was difficult to interpret in most of the species we examined. However, we saw what may have been CB1-positive amacrine cells in all species examined (Fig. 3 a and  c-e) . In the salamander, we saw faint INL somatic labeling that may correspond to Müller cells or amacrine cells (Fig. 3d) .
GCL and the Retinal Axon Layer. Labeling of the CB1 receptor was found in the GCL and retinal axon layers of all species examined except fish. However, the most striking results were found in the salamander and chick (Fig. 3 c and d) , where labeling was present both in ganglion cells and in the retinal axon layer and was particularly prominent in the chick where somatic labeling of ganglion cells was apparent.
Endogenous Cannabinoid Receptor Ligands. To determine whether endogenous cannabinoid lipids are present in retina, using GC͞MS we analyzed lipid extracts of rapidly dissected rat Voltage-gated calcium channel currents were elicited by depolarizing voltage steps from Ϫ70 mV to ϩ20 mV in 10-mV increments (Fig. 5) . Potassium currents were blocked by external tetraethylammonium (40 mM). Barium (10 mM) served as the charge carrier (replacing calcium) for the calcium channels. In all seven bipolar cells tested, the addition of 600 nM (four cells) or 1.5 M (three cells) WIN 55212-2, a CB1 receptor agonist, blocked the sustained calcium-channel current (Fig. 5a ). This calcium-channel current in bipolar cells of the tiger salamander has been shown to be carried by dihydropyridine-sensitive L-type calcium channels (23) . The L-type current was restored by the addition of a synthetic CB1 receptor antagonist, SR141716A
(450 nM-1 M). Subsequent wash of the agonist produced a substantial recovery of the calcium current. Mean peak amplitude of the control calcium current (0 mV) was Ϫ92 pA (SEM: 14pA, n ϭ 7). Mean peak amplitude of the calcium current with WIN 55212-2 was Ϫ28pA (SEM: 18pA) corresponding to a 70% inhibition of peak current (significant by paired t test, P Ͻ 0.05). A photomicrograph of a representative calcein-filled bipolar cell, in which L-channel current was inhibited by WIN 55212-2 is shown in Fig. 5c .
Discussion
Immunolabeling for the CB1 receptor was found in the OPL and IPL of all species examined. Notably, prominent CB1 staining was found in the synaptic terminals of the photoreceptors of monkey, mouse, rat, chick, fish, and salamander, and the inner and͞or outer segments of the photoreceptors of most species examined, strongly suggesting that cannabinoids act directly on the photoreceptors. All species appeared to possess CB1-positive amacrine cells. In the retinas of monkey, mouse, rat, chick, and salamander we also found labeling in ganglion cells and in the retinal axonal layer. The presence of cannabinoid receptors in the retina raises a number of interesting questions about the possible role of this receptor in vision and the potential effects of cannabinoid receptor activation on retinal function. CB1 labeling in the cone pedicles of monkey, chick, fish, and salamander (and probably in the rod spherules of all species) constitutes the most prominent The electrophysiological data from the present study indicate that activation of CB1 receptors modulates voltage-gated L-type calcium channels in retinal bipolar cell axon terminals. Although the immunohistochemical data did not conclusively identify CB1 in bipolar cells, the staining pattern in the IPL is consistent with the electrophysiological data, suggesting that CB1 is present in the bipolar cell axon terminals. Because L-type channels control glutamate release at these synapses (23) this finding suggests that cannabinoids modulate glutamatergic synaptic transmission between the second-order bipolar and amacrine cells and the downstream ganglion cells. Further, given the presence of CB1 receptors on photoreceptor synaptic terminals, glutamatergic synaptic transmission between photoreceptors and second-order cells also may be modulated by cannabinoids. If so, then given that photoreceptors respond to light signals by reducing glutamate release a predicted effect of cannabinoids might be to mimic the light activation of photoreceptors.
The presence of 2-AG, an endogenous ligand for CB1 receptors, clearly reinforces the notion of a cannabinoid receptorbased neuromodulatory system in retina. The fact that anandamide levels were not detectable by our method, which reliably measures quantities of anandamide as low as 0.4 pmol͞sample, is surprising. Because anandamide is likely produced ''on demand'' (26, 27) , it is possible that static levels such as those determined in the present experiments may only partially reflect the biosynthetic capacity of retinal tissue. Less likely, hydrolysis by anandamide amidohydrolase, which is present in the retina (28) , could account for our negative result. It should be noted, however, that anandamide has been detected in other areas of the brain with high levels of the amidohydrolase. Whether the cannabinoid signaling system of the retina differs from the rest of the brain (i.e., whether retina makes use only of 2-AG as an endogenous ligand) is an interesting issue that remains to be Identification of 2-AG, PEA, and OEA in rat retina by GC͞MS. Endogenous cannabinoid lipids 2-AG, PEA, and OEA were purified chromatographically from rat retina and analyzed by selected-ion monitoring GC͞MS as bis trimethylsilylethers. For quantification, deuterium-labeled standards were added to all samples. Representative tracings for selected fragments characteristic of endogenous 2-AG (a, mass-to-charge ratio, m͞z ϭ 432), synthetic addressed in greater detail. We were unable to determine which cell types are responsible for PEA and 2-AG release. Localization of PEA and 2-AG will be fundamental to an understanding of their roles in any retinal cannabinoid neuromodulatory system and should be a focus of future investigations. The presence of PEA, a CB2-like receptor agonist (19, 29) , is interesting in view of the recent localization of CB2 receptor mRNA in retina (30) . These immunohistochemical, biochemical, and electrophysiological observations, combined with those of other investigators (16) (17) (18) , give us reason to believe that CB1 receptors and possibly CB2 receptors, acting as part of a novel signaling system in the retina, play a substantive role in retinal function by inhibiting the calcium currents in bipolar cells that are responsible for calcium-dependent glutamatergic synaptic transmission (22) . Most of our results appear to be consistent across a wide range of vertebrate species, a conservation of form that may reflect a conservation of function. Most users of marijuana and hashish will readily describe perceived visual effects. Although our results open the possibility of a retinal cannabinoid role in vision, any of the diverse reported visual effects may be the result of action on CB1 receptors present in higher brain regions dedicated to vision (20) . As such, any hypothesized retinal cannabinoid effects on vision must await further study. We suggest that studying the role of cannabinoid receptors in the retina will yield a greater understanding of what promises to be a novel retinal signaling system and possibly shed light on visual effects of marijuana use. We further hope that this work will offer opportunities to relate endocannabinoid action with a specific function in the body.
